Journal article
Hope, quality of life, and benefit from treatment in women having chemotherapy for platinum-resistant/refractory recurrent ovarian cancer: the gynecologic cancer intergroup symptom benefit study.
- Abstract:
-
Chemotherapy for platinum-resistant/refractory ovarian cancer is motivated by the hope of benefit. We sought to determine the relationships between: (a) trait hope, expectation of symptom benefit from chemotherapy, and anxiety and depression; (b) hope and perceived efficacy of chemotherapy; and (c) unfulfilled hope (where expectations for benefit are not fulfilled) and depression. Methods. Adult patients enrolled within stage 1 of the Gynecologic Cancer Intergroup Symptom Benefit Study were i...
Expand abstract
Actions
Authors
Bibliographic Details
- Journal:
- oncologist
- Volume:
- 18
- Issue:
- 11
- Pages:
- 1221-1228
- Publication date:
- 2013-01-01
- DOI:
- EISSN:
-
1549-490X
- ISSN:
-
1083-7159
- Source identifiers:
-
435035
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:435035
- UUID:
-
uuid:6cebe753-2bb2-42e3-90f5-31a8fc9f3c5a
- Local pid:
- pubs:435035
- Deposit date:
- 2013-11-16
Terms of use
- Copyright date:
- 2013
If you are the owner of this record, you can report an update to it here: Report update to this record